Abstract
Parkinson’s disease (PD) is characterized by the progressive loss of dopamine neurons. Here, we describe how to use human SH-SY5Y neuroblastoma cells as an in vitro cell model to study the effects of candidate PD susceptibility genes on dopamine neuron differentiation and viability. This cell model can be used to study the effects of siRNA-induced gene knockdown, either alone or in combination with PD-related cellular stressors such as MPP+, and is compatible with high-throughput cellular screening platforms such as the Cellomics ArrayScan VTI HCS Reader.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lees, A. J., Hardy, J., and Revesz, T. (2009) Parkinson’s disease. Lancet 373, 2055–66.
Harrower, T. P., Michell, A. W., and Barker, R. A. (2005) Lewy bodies in parkinson’s disease: Protectors or perpetrators? Exp Neurol 195, 1–6.
Ross, C. A., and Poirier, M. A. (2004) Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl, S10–7.
Lee, F. J., and Liu, F. (2008) Genetic factors involved in the pathogenesis of parkinson’s disease. Brain Res Rev 58, 354–64.
Abou-Sleiman, P. M., Muqit, M. M., and Wood, N. W. (2006) Expanding insights of mitochondrial dysfunction in parkinson’s disease. Nat Rev Neurosci 7, 207–19.
Nicklas, W. J., Youngster, S. K., Kindt, M. V., and Heikkila, R. E. (1987) Mptp, mpp+ and mitochondrial function. Life Sci 40, 721–9.
Richardson, J. R., Caudle, W. M., Guillot, T. S., Watson, J. L., Nakamaru-Ogiso, E., Seo, B. B., Sherer, T. B., Greenamyre, J. T., Yagi, T., Matsuno-Yagi, A., and Miller, G. W. (2007) Obligatory role for complex i inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp). Toxicol Sci 95, 196–204.
Fitzgerald, J. C., and Plun-Favreau, H. (2008) Emerging pathways in genetic parkinson’s disease: Autosomal-recessive genes in parkinson’s disease--a common pathway? FEBS J 275, 5758–66.
Bossers, K., Meerhoff, G., Balesar, R., van Dongen, J. W., Kruse, C. G., Swaab, D. F., and Verhaagen, J. (2009) Analysis of gene expression in parkinson’s disease: Possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 19, 91–107.
Hamamichi, S., Rivas, R. N., Knight, A. L., Cao, S., Caldwell, K. A., and Caldwell, G. A. (2008) Hypothesis-based rnai screening identifies neuroprotective genes in a parkinson’s disease model. Proc Natl Acad Sci USA 105, 728–33.
Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., Andersen, S. L., Stephens, R. M., Benes, F. M., and Sonntag, K. C. (2009) Gene expression profiling of substantia nigra dopamine neurons: Further insights into parkinson’s disease pathology. Brain 132, 1795–809.
Acknowledgments
This work is supported by TI Pharma (project T5-207: Parkinson and Alzheimer disease: from dysregulated human brain targets towards novel therapeutics).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Blaas, E., van Kesteren, R.E. (2011). High-Throughput High-Content Functional Image Analysis of Neuronal Proteins Implicated in Parkinson’s Disease. In: Li, K. (eds) Neuroproteomics. Neuromethods, vol 57. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-111-6_16
Download citation
DOI: https://doi.org/10.1007/978-1-61779-111-6_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-110-9
Online ISBN: 978-1-61779-111-6
eBook Packages: Springer Protocols